The profile of prostate epithelial cytokines and its impact on sera prostate specific antigen levels

Inflammation

Volumn 32, Issue 3, 2009, Pages 202-210

  Bouraoui Mechergui, Yosra ^a   Ben Jemaa, Awatef ^a   Mezigh, Chekib ^b   Fraile, Benito ^c   Ben Rais, Nawfel ^b   Paniagua, Ricardo ^c   Royuela, Mar ^c   Oueslati, Ridha ^a  

^a University of Carthage   (Tunisia)

^b MILITARY HOSPITAL OF TUNIS   (Tunisia)

^c UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Benign hyperplasia prostate; Epithelial cells; IL 1 ; IL 6; Pro inflammatory cytokines; Prostate cancer; Prostate specific antigen (PSA); TNF

Indexed keywords

INTERLEUKIN 1ALPHA; INTERLEUKIN 6; PROSTATE SPECIFIC ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; AUTOANALYZER; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; OPTICAL DENSITY; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CYTOKINES; EPITHELIAL CELLS; HUMANS; INFLAMMATION; INTERLEUKIN-1ALPHA; INTERLEUKIN-6; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROTEOMICS;

EID: 67349148981     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10753-009-9121-7     Document Type: Article

References (45)

1. G. Dranoff 2004 Cytokines in cancer pathogenesis and cancer therapy Nat. Rev. Cancer 4 11 22 (Pubitemid 38111131)
2. C. A. Dinarello 2000 Proinflammatory cytokines Chest 118 503 508 (Pubitemid 30637822)
3. A. M. De Marzo T. L. DeWeese E. A. Platz 2004 Pathological and mechanisms of prostate carcinogenesis: Implication for diagnosis, detection, prevention and treatment J. Cell Biochem. 91 459 477
4. A. Panja S. Goldberg L. Eckmann 1998 The regulation and functional consequence of pro-inflammatory cytokine binding on human intestinal epithelial cells J. Immunol. 161 3675 3684 (Pubitemid 128470669)
5. D. Q. Li L. Luo Z. Chen 2006 JNK and ERK MAP kinases mediate induction of IL-1β, TNFα and IL-8 following hyperosmolar stress in human limbal epithelial cells Exp. Eye Res. 82 588 596 (Pubitemid 43122089)
6. P. Borger G. H. Koeter J. A. Timmerman 1999 Proteases from Aspergillus fumugatus induce interleukin (IL)-6 and IL-8 profuction in airway epithelial cell lines by transcriptional mechanisms J. Infect. Dis. 180 1267 1274 (Pubitemid 30070213)
7. M. Ricote I. Garcia-Tuñon F. R. Bethencourt 2004 Interleukin-1 (IL-1alpha and IL-1beta) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma Cancer 100 1388 1396 (Pubitemid 38366841)
8. A. Hobisch H. Rogatsch A. Hittmar 2000 Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue J. Pathol. 191 239 244 (Pubitemid 30441246)
9. J. T. Isaacs 1999 The biology of hormone refractory prostate cancer. Why does it develop? Urol. Clin. North Am. 26 263 273 (Pubitemid 29228223)
10. J. Trapman K. B. Cleutjens 1997 Androgen-regulated gene expression in prostate cancer Semin. Cancer Biol. 8 29 36 (Pubitemid 27417427)
11. S. O. Lee W. Lou M. Hou 2003 Interleukin-4 enhances prostate specific antigen expression by activation of the androgen receptor and AKT pathway Oncogene 22 6037 6044 (Pubitemid 37175863)
12. S. O. Lee W. Lou M. Hou 2003 Interleukin-6 promotes androgen-independent growth in LNCaP human prostate cancer cells Clin. Cancer Res. 9 370 376 (Pubitemid 36109754)
13. H. Lilja 1993 Structure, function and regulation of the enzyme activity of prostate-specific antigen World J. Urol. 11 188 191
14. G. M. Yousef E. P. Diamandis 2001 The new human tissue kallikrein gene family: Structure, function, and association to disease Endocr. Rev. 22 184 204 (Pubitemid 32458158)
15. R. Lieberman 2004 Evidence-based medical perspectives: The evolving role of PSA for early detection, monitoring of treatment response and as a surrogate end point of efficacy for interventions in men with different clinical states for the prevention and progression of prostate cancer Am. J. Ther. 11 501 506
16. W. J. Catalona A. W. Partin K. M. Slawin 1998 Use the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: A prospective multicenter clinical trial JAMA 297 1542 1547 (Pubitemid 28233009)
17. S. P. Balk Y. J. Ko G. J. Bubley 2003 Biology of prostate-specific antigen J. Clin. Oncol. 21 383 391 (Pubitemid 46606169)
18. V. Michalaki K. Syrigos P. Charles 2004 Serum levels of IL-6 and TNFα correlate with clinicopathological features and patients survival in patients with prostate cancer Br. J. Cancer 90 2312 2316 (Pubitemid 38961893)
19. A. Mizokami A. Gotoh H. Yamada 2000 Tumor necrosis factor-alpha represses androgen sensitivity in LNCaP prostate cancer cell line J. Urol. 164 800 805 (Pubitemid 30637637)
20. F. Balkwill A. Mantovani 2001 Inflammation and cancer. Back to virchow? Lancet 357 539 545 (Pubitemid 32173595)
21. L. M. Coussen Z. Werb 2002 Inflammation and cancer Nature 420 860 867 (Pubitemid 36019639)
22. C. E. Lewis J. W. Pollard 2006 Distinct role of macrophages in different tumor microenvironment Cancer Res. 66 605 612 (Pubitemid 43165918)
23. Y. Bouraoui M. Ricote I. García-Tuñón 2008 Pro-inflammatory cytokines and prostate-specific antigen in hyperplasia and human prostate cancer Cancer Detect. Prev. 32 23 32
24. J. Wilson F. Balkwill 2002 The role of cytokines in the epithelial cancer microenvironment Semin. Cancer Biol. 12 113 120 (Pubitemid 34680740)
25. K. E. De Visser A. Eichten L. M. Coussen 2006 Paradoxal roles of the immune system during cancer development Nat. Rev. Cancer 6 24 37 (Pubitemid 43053650)
26. L. Yan G. M. Anderson M. Dewitte 2006 Therapeutic potential of cytokine and chemokine antagonists in cancer therapy Eur. J. Cancer 42 793 802
27. P. Gastro D. Giri D. Lamb 2003 Cellular Senescence in the pathogenesis of benign prostatic hyperplasia Prostate 55 30 38 (Pubitemid 36397742)
28. J. T. Anim C. Udo B. John 1998 Characterisation of inflammatory cells in benign prostatic hyperplasia BJU Int. 84 976 978 (Pubitemid 28524620)
29. C. A. Dinarello 1996 Biologic basis for interleukin-1 in disease Blood 87 2095 (Pubitemid 26086851)
30. K. Okada M. Kojima Y. Naya 2000 Correlation of histological inflammation in needle biopsy specimens with serum prostate antigen levels in men with negative biopsy for prostate cancer Urology 55 892 898 (Pubitemid 30330795)
31. J. Nakashima M. Tachibana Y. Horiguchi 2000 Serum interleukin 6 as a prognostic factor in patients with prostate cancer Clin. Cancer Res. 6 2702 2706 (Pubitemid 30482107)
32. S. F. Shariat B. Andrew M. W. Katten 2001 Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis Urology 58 1008 1015 (Pubitemid 34017290)
33. K. Ishihara T. Hirano 2002 IL-6 in auto-immune disease and chronic inflammatory proliferative disease Cytokine Growth Factor Rev. 13 357 368
34. A. A. Luderer Y. T. Chen T. F. Soriano 1995 Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen Urology 46 187 194
35. Y. Bouraoui N. Ben Rais Z. Elouni 2006 Evolution's molecular forms of Prostate-Specific-Antigen in serological groups of patients with prostatic pathologies Immunobiology 21 286 291 (Pubitemid 44486664)
36. J. E. Oesterling 1991 Prostate specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate J. Urol. 145 907 923
37. A. Brunet A. Bonni M. J. Zigmond 1999 AKT promote cell survival by transcription phosphorylating and inhibiting a Forkhead transcription factor Cell 96 857 868 (Pubitemid 29165088)
38. M. H. Cardonne N. Roy H. R. Stennicke 1998 Regulation of cell death protease caspase-9 by phosphorylating Science 282 1318 1321 (Pubitemid 28524494)
39. J. Paez W. R. Sellers 2003 PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling Cancer Treat. Res. 115 145 167
40. S. O. Lee W. Lou N. Nadiminty 2005 Requirement for NFκB in interleukin-4-induced androgen receptor activation in prostate cancer cells Prostate 64 160 167 (Pubitemid 40791765)
41. M. Mikhailova Y. Wang R. Bedolla X. H. Lu J. I. Kreisberg P. M. Ghosh 2008 AKT regulates androgen receptor-dependent growth and PSA expression in prostate cancer Adv. Exp. Med. Biol. 617 397 405
42. M. Paliouras E. P. Diamandis 2008 An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines Biol. Chem. 389 773 780
43. N. Sizemore S. Leung G. R. Strak 1999 Activation of phosphatidylinositol 3-Kinase in response to inerleukin-1 leads to phosphorylation and activation of the NF-κB p65/RelA subnit Mol. Cell. Biol. 19 4798 4805 (Pubitemid 29289518)
44. P. Cohen H. C. Graves D. M. Peehl 1992 Prostate specific antigen as an insulin-like growth factor binding protein-3protease found in seminal plasma J. Clin. Endocrinol. Metab. 75 1046 1053
45. M. M. Webber A. Waghray D. Bello 1995 Prostate specific antigen, a serine protease facilitate human prostate cancer cell invasion Clin. Cancer Res. 1 1089 1094